{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:05:03Z","timestamp":1761109503824},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1054\/blre.2001.0186","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T07:33:30Z","timestamp":1027668810000},"page":"65-67","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacoeconomics of therapy for ITP: steroids, IVIg, anti-D, and splenectomy"],"prefix":"10.1054","volume":"16","author":[{"given":"J.R.","family":"Adams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.P.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.L.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/blre.2001.0186_RF1","first-page":"58","article-title":"Idiopathic thrombocytopenic purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy","volume":"35","author":"Simpson","year":"1998","journal-title":"Semin Hematol"},{"key":"10.1054\/blre.2001.0186_RF2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2141.1985.tb02985.x","article-title":"Management of idiopathic thrombocytopenic purpura in adults","volume":"59","author":"McVerry","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0186_RF3","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood.V89.8.2689","article-title":"Intravenous anti-D treatment of immune thrombocytopenia purpura: Experience in 272 patients","volume":"89","author":"Scaradavou","year":"1997","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0186_RF4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/(SICI)1096-8652(200003)63:3<156::AID-AJH9>3.0.CO;2-4","article-title":"The cost of treating immune thrombocytopenic purpura using intravenous Rh immune globulin versus intravenous immune globulin","volume":"63","author":"Sandler","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0186_RF5","unstructured":"Medical Economics Inc. 2000 Red Book, August 2001 update, Montvale, New Jersey, Medical Economics Company, Inc. 2000"},{"key":"10.1054\/blre.2001.0186_RF6","unstructured":"Medical diagnosis and procedure coding, www.eICD.com."},{"key":"10.1054\/blre.2001.0186_RF7","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1365-2141.2001.02627.x","article-title":"A dose of 75 microg\/kg\/d of i.v. anti-D increases the plateletcount more rapidly and for a longer period of time than 50 microg\/kg\/d in adults with immune thrombocytopenic purpura","volume":"112","author":"Newman","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0186_RF8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0037-1963(00)90115-X","article-title":"The potential for treatment of idiopathic thrombocytopenic purpura with anti-D to prevent splenectomy: a predictive cost analysis","volume":"37","author":"Bennett","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1054\/blre.2001.0186_RF9","unstructured":"Tarantino, M. Adams, J. Golub, R. The risk of intracranial hemorrhage (ICH) in pediatric patients with acute immune thrombocytopenic purpura (ITP): An economic analysis, HaemostasisThrombosis, 2001, 85, 1147"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X01901869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X01901869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T17:35:43Z","timestamp":1581010543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X01901869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S0268960X01901869"],"URL":"https:\/\/doi.org\/10.1054\/blre.2001.0186","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}